A detailed history of Meeder Advisory Services, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 1,931 shares of MRNA stock, worth $224,864. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,931
Holding current value
$224,864
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$85.37 - $115.44 $164,849 - $222,914
1,931 New
1,931 $206 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $132,274 - $173,708
-1,372 Reduced 40.72%
1,997 $206 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $97,762 - $132,437
-825 Reduced 19.67%
3,369 $409 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $22,519 - $32,705
166 Added 4.12%
4,194 $644 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $476,834 - $846,041
4,028 New
4,028 $724 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Meeder Advisory Services, Inc. Portfolio

Follow Meeder Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meeder Advisory Services, Inc. with notifications on news.